Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Cancer Metastatic × palbociclib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Breast 1

Conditions

Breast Neoplasms 35 Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Advanced Breast Cancer 3 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Inflammation 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Thromboembolism 1 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Primary Myelofibrosis 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Docetaxel 2 palbociclib 1 nirogacestat 1 Trastuzumab 1 Rogaratinib 1 Fulvestrant 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡